Cargando…
Nifedipine in Congenital Hyperinsulinism- A Case Report
Congenital hyperinsulinism (CHI) is the commonest cause of persistent hypoglycemia in neonates. Diazoxide is the first-line drug in its treatment, but the more severe cases are usually diazoxide-resistant. Recessive ABCC8 and KCNJ11 mutations are responsible for most (82%) of the severe diazoxide-un...
Autores principales: | Khawash, Papiya, Hussain, Khalid, Flanagan, Sarah E., Chatterjee, Sudip, Basak, Dhananjoy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563189/ https://www.ncbi.nlm.nih.gov/pubmed/26316440 http://dx.doi.org/10.4274/jcrpe.1978 |
Ejemplares similares
-
Familial Focal Congenital Hyperinsulinism
por: Ismail, Dunia, et al.
Publicado: (2011) -
Congenital hyperinsulinism: 2 case reports with different rare variants in ABCC8
por: Mouron-Hryciuk, Julie, et al.
Publicado: (2021) -
Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism
por: Kapoor, Ritika R, et al.
Publicado: (2013) -
A Case Series: Congenital Hyperinsulinism
por: Alaei, Mohammad Reza, et al.
Publicado: (2016) -
Congenital Hyperinsulinism and Evolution to Sulfonylurearesponsive Diabetes Later in Life due to a Novel Homozygous p.L171F ABCC8 Mutation
por: Işık, Emregül, et al.
Publicado: (2019)